4//SEC Filing
Bruehlman Ronald E 4
Accession 0001809519-24-000202
CIK 0001809519other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:39 PM ET
Size
10.0 KB
Accession
0001809519-24-000202
Insider Transaction Report
Form 4
Bruehlman Ronald E
Director
Transactions
- Award
Class A Common Stock
2024-11-08+1,128→ 1,128 total - Award
Class A Common Stock
2024-11-08+20,503→ 21,631 total - Award
Deferred Stock Unit
2024-11-08+65,075→ 65,075 total→ Class A Common Stock (65,075 underlying)
Footnotes (4)
- [F1]Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments on the last calendar day for each remaining month of the 2024 calendar year, beginning on November 30, 2024, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
- [F2]Reflects deferred stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
- [F3]Each deferred stock unit represents a contingent right to receive one share of Class A common stock.
- [F4]The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 8, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001604076
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:39 PM ET
- Size
- 10.0 KB